siRNA, Anti-Human ANXA2, LNA(CAT#: SIRGT04194WQ-LNA)

The product SIRGT04194WQ-LNA is a type of small interfering RNA (siRNA) that targets ANXA2 gene and regulates the expression of gene. The siRNA interferes with the expression of ANXA2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_001002857.1; NM_001002858.2; NM_001136015.2; NM_004039.2
Alternative Names ANX2; ANX2L4; CAL1H; HEL-S-270; LIP2; LPC2; LPC2D; P36; PAP-IV
Related Diseases Antiphospholipid Syndrome, Acute Promyelocytic Leukemia
Purification HPLC
Target Gene
Gene ID 302
Uniprot ID P07355

Related Products